Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cutaquig in patients intolerant to other subcutaneous immunoglobulin products
NCT03677557Phase 4Unknown
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Sep 2018
- Primary completion
- Aug 2021
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of polyvalent human immunoglobulin in primary immunodeficiency disease (PID), secondary immunodeficiency (SID), sponsored by Ottawa Hospital Research Institute. Status: unknown.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
primary immunodeficiency disease (PID)secondary immunodeficiency (SID)
Beyond the preview
Go deeper on NCT03677557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03677557.